Southwest Gastroenterology

1. Irritable Bowel Syndrome Study by Tioga Pharmaceuticals:

A 12 week Randomized, double-blind, Placebo-controlled study of Asimadoline in subjects with Diarrhea-predominant Irritable Bowel Syndrome.

2. Irritable Bowel Syndrome with Furiex Pharmaceuticals:

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of Investigational Product in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome